Record Information |
---|
Version | 5.0 |
---|
Status | Detected and Quantified |
---|
Creation Date | 2005-11-16 15:48:42 UTC |
---|
Update Date | 2021-11-15 21:04:30 UTC |
---|
HMDB ID | HMDB0000582 |
---|
Secondary Accession Numbers | - HMDB0000627
- HMDB00582
- HMDB00627
|
---|
Metabolite Identification |
---|
Common Name | 3,5-Diiodothyronine |
---|
Description | 3,5-Diiodothyronine, also known as 3,5-T2, belongs to the class of organic compounds known as phenylalanines and derivatives. Phenylalanine and derivatives are compounds containing phenylalanine or a derivative thereof resulting from reaction of phenylalanine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. It is also a member of the class of compounds known as iodothyronines. Iodothyronines are phenolic amino acids with iodine substituents. 3,5-Diiodothyronine is a metabolite of the two main thyroid hormones T3 and T4 (thyroxine and triiodo-L-thyronine). It is a biologically active iodothyronine with mitochondria and bioenergetic mechanisms being the major targets of 3,5-T2. Nanomolar concentrations of 3,5-T2 significantly increases cytochrome oxidase (COX) activity (PMID: 30090086 ). It increases COX activity by preventing the interaction of adenosine triphosphate (ATP) as an allosteric inhibitor. At 1 pM concentration, 3,5-T2 stimulates oxygen consumption more rapidly than thyroxine (T3). A case report involving two human participants revealed that administration of 3,5-T2 to humans (1-5 ug/kg BW) rapidly (after 4-6 h) increased resting metabolic rate. Chronic 3,5-T2 administration (28 days, approximately 5 ug/kg BW) increased resting metabolic rate by approximately 15% and decreased body weight by approximately 4 kg in both participants (PMID: 22217997 ). 3,5-T2 stimulates the thyroid receptor (TR)-beta receptor for thyroid hormones and thus increases energy expenditure. It has agonistic (thyromimetic) effects on myocardial tissue and on the pituitary, which results in 3,5-T2 suppressing thyroid stimulating hormone release. |
---|
Structure | NC(CC1=CC(I)=C(OC2=CC=C(O)C=C2)C(I)=C1)C(O)=O InChI=1S/C15H13I2NO4/c16-11-5-8(7-13(18)15(20)21)6-12(17)14(11)22-10-3-1-9(19)2-4-10/h1-6,13,19H,7,18H2,(H,20,21) |
---|
Synonyms | Value | Source |
---|
35-Diiodothyronine | HMDB | (3,5-Diiodo-4-(-p-hydroxyphenoxy)phenyl)-alanine | HMDB | 3',5'-Diiodothyronine | HMDB | 3,5-Diiodo-D-thyronine | HMDB | 3,5-Diiodo-DL-thryronine | HMDB | 3,5-Diiodo-DL-thyronine | HMDB | 3,5-Diiodo-L-thyronine | HMDB | 3,5-T2 | HMDB | 4-(4-Hydroxyphenoxy)-3,5-diiodophenylalanine | HMDB | D-O-(4-Hydroxyphenyl)-3,5-diiodo-tyrosine | HMDB | Diiodo-L-thyronine | HMDB | Diiodothyronine | HMDB | DL-3,5-Diiodothyronine | HMDB | DL-Diiodothyronine | HMDB | L-3,5-Diiodothyronine | HMDB | L-O-(4-Hydroxyphenyl)-3,5-diiodo-tyrosine | HMDB | O-(4-Hydroxyphenyl)-3,5-diiodo-tyrosine | HMDB | 3,5-Diiodothyronine, (L)-isomer | HMDB | 3,5-Diiodothyronine, (DL)-isomer | HMDB | 2-Amino-3-[4-(4-hydroxyphenoxy)-3,5-diiodophenyl]propanoate | HMDB | 3,5-Diiodothyronine | MeSH |
|
---|
Chemical Formula | C15H13I2NO4 |
---|
Average Molecular Weight | 525.077 |
---|
Monoisotopic Molecular Weight | 524.893394749 |
---|
IUPAC Name | 2-amino-3-[4-(4-hydroxyphenoxy)-3,5-diiodophenyl]propanoic acid |
---|
Traditional Name | 3,5-diiodo-dl-thryronine |
---|
CAS Registry Number | 534-51-0 |
---|
SMILES | NC(CC1=CC(I)=C(OC2=CC=C(O)C=C2)C(I)=C1)C(O)=O |
---|
InChI Identifier | InChI=1S/C15H13I2NO4/c16-11-5-8(7-13(18)15(20)21)6-12(17)14(11)22-10-3-1-9(19)2-4-10/h1-6,13,19H,7,18H2,(H,20,21) |
---|
InChI Key | ZHSOTLOTTDYIIK-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as phenylalanine and derivatives. Phenylalanine and derivatives are compounds containing phenylalanine or a derivative thereof resulting from reaction of phenylalanine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organic acids and derivatives |
---|
Class | Carboxylic acids and derivatives |
---|
Sub Class | Amino acids, peptides, and analogues |
---|
Direct Parent | Phenylalanine and derivatives |
---|
Alternative Parents | |
---|
Substituents | - Phenylalanine or derivatives
- Diphenylether
- Diaryl ether
- 3-phenylpropanoic-acid
- Alpha-amino acid
- Amphetamine or derivatives
- Phenoxy compound
- Phenol ether
- Iodobenzene
- Halobenzene
- 1-hydroxy-2-unsubstituted benzenoid
- Phenol
- Aralkylamine
- Aryl iodide
- Aryl halide
- Benzenoid
- Monocyclic benzene moiety
- Amino acid
- Ether
- Carboxylic acid
- Monocarboxylic acid or derivatives
- Organic nitrogen compound
- Primary aliphatic amine
- Organohalogen compound
- Organoiodide
- Organonitrogen compound
- Organooxygen compound
- Primary amine
- Carbonyl group
- Hydrocarbon derivative
- Organic oxide
- Organopnictogen compound
- Organic oxygen compound
- Amine
- Aromatic homomonocyclic compound
|
---|
Molecular Framework | Aromatic homomonocyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Not Available | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Experimental Collision Cross Sections |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
3,5-Diiodothyronine,1TMS,isomer #1 | C[Si](C)(C)OC1=CC=C(OC2=C(I)C=C(CC(N)C(=O)O)C=C2I)C=C1 | 3202.0 | Semi standard non polar | 33892256 | 3,5-Diiodothyronine,1TMS,isomer #2 | C[Si](C)(C)OC(=O)C(N)CC1=CC(I)=C(OC2=CC=C(O)C=C2)C(I)=C1 | 3216.0 | Semi standard non polar | 33892256 | 3,5-Diiodothyronine,1TMS,isomer #3 | C[Si](C)(C)NC(CC1=CC(I)=C(OC2=CC=C(O)C=C2)C(I)=C1)C(=O)O | 3265.9 | Semi standard non polar | 33892256 | 3,5-Diiodothyronine,2TMS,isomer #1 | C[Si](C)(C)OC(=O)C(N)CC1=CC(I)=C(OC2=CC=C(O[Si](C)(C)C)C=C2)C(I)=C1 | 3221.8 | Semi standard non polar | 33892256 | 3,5-Diiodothyronine,2TMS,isomer #2 | C[Si](C)(C)NC(CC1=CC(I)=C(OC2=CC=C(O[Si](C)(C)C)C=C2)C(I)=C1)C(=O)O | 3210.0 | Semi standard non polar | 33892256 | 3,5-Diiodothyronine,2TMS,isomer #3 | C[Si](C)(C)NC(CC1=CC(I)=C(OC2=CC=C(O)C=C2)C(I)=C1)C(=O)O[Si](C)(C)C | 3184.6 | Semi standard non polar | 33892256 | 3,5-Diiodothyronine,2TMS,isomer #4 | C[Si](C)(C)N(C(CC1=CC(I)=C(OC2=CC=C(O)C=C2)C(I)=C1)C(=O)O)[Si](C)(C)C | 3357.2 | Semi standard non polar | 33892256 | 3,5-Diiodothyronine,3TMS,isomer #1 | C[Si](C)(C)NC(CC1=CC(I)=C(OC2=CC=C(O[Si](C)(C)C)C=C2)C(I)=C1)C(=O)O[Si](C)(C)C | 3191.5 | Semi standard non polar | 33892256 | 3,5-Diiodothyronine,3TMS,isomer #1 | C[Si](C)(C)NC(CC1=CC(I)=C(OC2=CC=C(O[Si](C)(C)C)C=C2)C(I)=C1)C(=O)O[Si](C)(C)C | 2850.1 | Standard non polar | 33892256 | 3,5-Diiodothyronine,3TMS,isomer #1 | C[Si](C)(C)NC(CC1=CC(I)=C(OC2=CC=C(O[Si](C)(C)C)C=C2)C(I)=C1)C(=O)O[Si](C)(C)C | 3105.1 | Standard polar | 33892256 | 3,5-Diiodothyronine,3TMS,isomer #2 | C[Si](C)(C)OC1=CC=C(OC2=C(I)C=C(CC(C(=O)O)N([Si](C)(C)C)[Si](C)(C)C)C=C2I)C=C1 | 3352.8 | Semi standard non polar | 33892256 | 3,5-Diiodothyronine,3TMS,isomer #2 | C[Si](C)(C)OC1=CC=C(OC2=C(I)C=C(CC(C(=O)O)N([Si](C)(C)C)[Si](C)(C)C)C=C2I)C=C1 | 3037.3 | Standard non polar | 33892256 | 3,5-Diiodothyronine,3TMS,isomer #2 | C[Si](C)(C)OC1=CC=C(OC2=C(I)C=C(CC(C(=O)O)N([Si](C)(C)C)[Si](C)(C)C)C=C2I)C=C1 | 3284.8 | Standard polar | 33892256 | 3,5-Diiodothyronine,3TMS,isomer #3 | C[Si](C)(C)OC(=O)C(CC1=CC(I)=C(OC2=CC=C(O)C=C2)C(I)=C1)N([Si](C)(C)C)[Si](C)(C)C | 3311.9 | Semi standard non polar | 33892256 | 3,5-Diiodothyronine,3TMS,isomer #3 | C[Si](C)(C)OC(=O)C(CC1=CC(I)=C(OC2=CC=C(O)C=C2)C(I)=C1)N([Si](C)(C)C)[Si](C)(C)C | 3011.1 | Standard non polar | 33892256 | 3,5-Diiodothyronine,3TMS,isomer #3 | C[Si](C)(C)OC(=O)C(CC1=CC(I)=C(OC2=CC=C(O)C=C2)C(I)=C1)N([Si](C)(C)C)[Si](C)(C)C | 3246.9 | Standard polar | 33892256 | 3,5-Diiodothyronine,4TMS,isomer #1 | C[Si](C)(C)OC(=O)C(CC1=CC(I)=C(OC2=CC=C(O[Si](C)(C)C)C=C2)C(I)=C1)N([Si](C)(C)C)[Si](C)(C)C | 3361.2 | Semi standard non polar | 33892256 | 3,5-Diiodothyronine,4TMS,isomer #1 | C[Si](C)(C)OC(=O)C(CC1=CC(I)=C(OC2=CC=C(O[Si](C)(C)C)C=C2)C(I)=C1)N([Si](C)(C)C)[Si](C)(C)C | 3007.0 | Standard non polar | 33892256 | 3,5-Diiodothyronine,4TMS,isomer #1 | C[Si](C)(C)OC(=O)C(CC1=CC(I)=C(OC2=CC=C(O[Si](C)(C)C)C=C2)C(I)=C1)N([Si](C)(C)C)[Si](C)(C)C | 3019.0 | Standard polar | 33892256 | 3,5-Diiodothyronine,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC1=CC=C(OC2=C(I)C=C(CC(N)C(=O)O)C=C2I)C=C1 | 3478.8 | Semi standard non polar | 33892256 | 3,5-Diiodothyronine,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC(=O)C(N)CC1=CC(I)=C(OC2=CC=C(O)C=C2)C(I)=C1 | 3487.6 | Semi standard non polar | 33892256 | 3,5-Diiodothyronine,1TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)NC(CC1=CC(I)=C(OC2=CC=C(O)C=C2)C(I)=C1)C(=O)O | 3524.0 | Semi standard non polar | 33892256 | 3,5-Diiodothyronine,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)C(N)CC1=CC(I)=C(OC2=CC=C(O[Si](C)(C)C(C)(C)C)C=C2)C(I)=C1 | 3725.5 | Semi standard non polar | 33892256 | 3,5-Diiodothyronine,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)NC(CC1=CC(I)=C(OC2=CC=C(O[Si](C)(C)C(C)(C)C)C=C2)C(I)=C1)C(=O)O | 3735.7 | Semi standard non polar | 33892256 | 3,5-Diiodothyronine,2TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)NC(CC1=CC(I)=C(OC2=CC=C(O)C=C2)C(I)=C1)C(=O)O[Si](C)(C)C(C)(C)C | 3719.1 | Semi standard non polar | 33892256 | 3,5-Diiodothyronine,2TBDMS,isomer #4 | CC(C)(C)[Si](C)(C)N(C(CC1=CC(I)=C(OC2=CC=C(O)C=C2)C(I)=C1)C(=O)O)[Si](C)(C)C(C)(C)C | 3820.5 | Semi standard non polar | 33892256 | 3,5-Diiodothyronine,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)NC(CC1=CC(I)=C(OC2=CC=C(O[Si](C)(C)C(C)(C)C)C=C2)C(I)=C1)C(=O)O[Si](C)(C)C(C)(C)C | 3936.0 | Semi standard non polar | 33892256 | 3,5-Diiodothyronine,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)NC(CC1=CC(I)=C(OC2=CC=C(O[Si](C)(C)C(C)(C)C)C=C2)C(I)=C1)C(=O)O[Si](C)(C)C(C)(C)C | 3523.4 | Standard non polar | 33892256 | 3,5-Diiodothyronine,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)NC(CC1=CC(I)=C(OC2=CC=C(O[Si](C)(C)C(C)(C)C)C=C2)C(I)=C1)C(=O)O[Si](C)(C)C(C)(C)C | 3393.5 | Standard polar | 33892256 | 3,5-Diiodothyronine,3TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC1=CC=C(OC2=C(I)C=C(CC(C(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C2I)C=C1 | 4073.5 | Semi standard non polar | 33892256 | 3,5-Diiodothyronine,3TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC1=CC=C(OC2=C(I)C=C(CC(C(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C2I)C=C1 | 3616.3 | Standard non polar | 33892256 | 3,5-Diiodothyronine,3TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC1=CC=C(OC2=C(I)C=C(CC(C(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C2I)C=C1 | 3476.7 | Standard polar | 33892256 | 3,5-Diiodothyronine,3TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)OC(=O)C(CC1=CC(I)=C(OC2=CC=C(O)C=C2)C(I)=C1)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 4043.1 | Semi standard non polar | 33892256 | 3,5-Diiodothyronine,3TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)OC(=O)C(CC1=CC(I)=C(OC2=CC=C(O)C=C2)C(I)=C1)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3617.7 | Standard non polar | 33892256 | 3,5-Diiodothyronine,3TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)OC(=O)C(CC1=CC(I)=C(OC2=CC=C(O)C=C2)C(I)=C1)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3440.5 | Standard polar | 33892256 |
|
---|
Spectra |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - 3,5-Diiodothyronine GC-MS (Non-derivatized) - 70eV, Positive | splash10-004i-5200920000-b93c897ae4b72c23519b | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 3,5-Diiodothyronine GC-MS (2 TMS) - 70eV, Positive | splash10-00di-9600058000-453c4267903543f11c76 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 3,5-Diiodothyronine GC-MS (TMS_1_1) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 3,5-Diiodothyronine GC-MS (TMS_1_2) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 3,5-Diiodothyronine GC-MS (TMS_1_3) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 3,5-Diiodothyronine GC-MS (TMS_2_2) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 3,5-Diiodothyronine GC-MS (TMS_2_3) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 3,5-Diiodothyronine GC-MS (TMS_2_4) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 3,5-Diiodothyronine GC-MS (TBDMS_1_1) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 3,5-Diiodothyronine GC-MS (TBDMS_1_2) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 3,5-Diiodothyronine GC-MS (TBDMS_1_3) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 3,5-Diiodothyronine GC-MS (TBDMS_2_1) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 3,5-Diiodothyronine GC-MS (TBDMS_2_2) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 3,5-Diiodothyronine GC-MS (TBDMS_2_3) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 3,5-Diiodothyronine GC-MS (TBDMS_2_4) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental LC-MS/MS | LC-MS/MS Spectrum - 3,5-Diiodothyronine Quattro_QQQ 10V, Positive-QTOF (Annotated) | splash10-004i-0000090000-0c32e1647fb8ad73f0b7 | 2012-07-24 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 3,5-Diiodothyronine Quattro_QQQ 25V, Positive-QTOF (Annotated) | splash10-003r-0003970000-f35e706ebe5a01fd53a0 | 2012-07-24 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 3,5-Diiodothyronine Quattro_QQQ 40V, Positive-QTOF (Annotated) | splash10-0fb9-0129700000-6535af9505fe3bcdc464 | 2012-07-24 | HMDB team, MONA | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3,5-Diiodothyronine 10V, Positive-QTOF | splash10-004i-0100890000-a4c3898b3f5e77f46dbe | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3,5-Diiodothyronine 20V, Positive-QTOF | splash10-004i-0000910000-e0bf5e5b19dbc8da3983 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3,5-Diiodothyronine 40V, Positive-QTOF | splash10-016u-2009200000-ed00e535f6a635c85b0f | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3,5-Diiodothyronine 10V, Negative-QTOF | splash10-00di-0100090000-71fa162482707b5eb3d7 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3,5-Diiodothyronine 20V, Negative-QTOF | splash10-0ab9-1600390000-2a1c97e2e04e68ad8521 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3,5-Diiodothyronine 40V, Negative-QTOF | splash10-05iu-9102200000-a695396d7ea8bb382a70 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3,5-Diiodothyronine 10V, Positive-QTOF | splash10-004i-0000290000-18b94b7e0180ef2e9c95 | 2021-09-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3,5-Diiodothyronine 20V, Positive-QTOF | splash10-004i-0000920000-c6b727eb99ca0e5a1992 | 2021-09-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3,5-Diiodothyronine 40V, Positive-QTOF | splash10-004i-4203900000-460478b6a64a00caf41a | 2021-09-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3,5-Diiodothyronine 10V, Negative-QTOF | splash10-00di-0000090000-2c48801ad2bd401ad2c3 | 2021-09-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3,5-Diiodothyronine 20V, Negative-QTOF | splash10-00fr-1800290000-803aa569bbb8878983f9 | 2021-09-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3,5-Diiodothyronine 40V, Negative-QTOF | splash10-004i-0900000000-0dba40d354fa6a5575e0 | 2021-09-24 | Wishart Lab | View Spectrum |
NMR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Experimental 2D NMR | [1H, 13C]-HSQC NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | 2012-12-05 | Wishart Lab | View Spectrum |
|
---|
Biological Properties |
---|
Cellular Locations | |
---|
Biospecimen Locations | |
---|
Tissue Locations | |
---|
Pathways | |
---|
Normal Concentrations |
---|
| |
Blood | Detected and Quantified | 0.000016 +/- 0.000006 uM | Adult (>18 years old) | Both | Normal | | details | Urine | Detected and Quantified | 0.000018 umol/mmol creatinine | Adult (>18 years old) | Both | Normal | | details |
|
---|
Abnormal Concentrations |
---|
| |
Blood | Detected and Quantified | 0.000046 +/- 0.000048 uM | Adult (>18 years old) | Both | Sepsis | | details | Blood | Detected and Quantified | 0.000024 +/- 0.000014 uM | Adult (>18 years old) | Both | Cirrhosis | | details | Blood | Detected and Quantified | 0.000021 +/- 0.000005 uM | Adult (>18 years old) | Both | Brain tumors | | details | Urine | Detected and Quantified | 0.000086 umol/mmol creatinine | Adult (>18 years old) | Both | Hyperthyroidism | | details | Urine | Detected and Quantified | 0.00001 umol/mmol creatinine | Adult (>18 years old) | Both | Hypothyroidism | | details |
|
---|
Associated Disorders and Diseases |
---|
Disease References | Sepsis |
---|
- Pinna G, Meinhold H, Hiedra L, Thoma R, Hoell T, Graf KJ, Stoltenburg-Didinger G, Eravci M, Prengel H, Brodel O, Finke R, Baumgartner A: Elevated 3,5-diiodothyronine concentrations in the sera of patients with nonthyroidal illnesses and brain tumors. J Clin Endocrinol Metab. 1997 May;82(5):1535-42. [PubMed:9141546 ]
| Cirrhosis |
---|
- Pinna G, Meinhold H, Hiedra L, Thoma R, Hoell T, Graf KJ, Stoltenburg-Didinger G, Eravci M, Prengel H, Brodel O, Finke R, Baumgartner A: Elevated 3,5-diiodothyronine concentrations in the sera of patients with nonthyroidal illnesses and brain tumors. J Clin Endocrinol Metab. 1997 May;82(5):1535-42. [PubMed:9141546 ]
| Brain tumors |
---|
- Pinna G, Meinhold H, Hiedra L, Thoma R, Hoell T, Graf KJ, Stoltenburg-Didinger G, Eravci M, Prengel H, Brodel O, Finke R, Baumgartner A: Elevated 3,5-diiodothyronine concentrations in the sera of patients with nonthyroidal illnesses and brain tumors. J Clin Endocrinol Metab. 1997 May;82(5):1535-42. [PubMed:9141546 ]
| Hyperthyroidism |
---|
- Hommel E, Faber J, Kirkegaard C, Siersbaek-Nielsen K, Friis T: Urinary excretion of unconjugated and conjugated 3,5-diiodothyronine. Horm Metab Res. 1985 Feb;17(2):90-2. [PubMed:3988241 ]
| Hypothyroidism |
---|
- Hommel E, Faber J, Kirkegaard C, Siersbaek-Nielsen K, Friis T: Urinary excretion of unconjugated and conjugated 3,5-diiodothyronine. Horm Metab Res. 1985 Feb;17(2):90-2. [PubMed:3988241 ]
|
|
---|
Associated OMIM IDs | None |
---|
External Links |
---|
DrugBank ID | Not Available |
---|
Phenol Explorer Compound ID | Not Available |
---|
FooDB ID | FDB022128 |
---|
KNApSAcK ID | Not Available |
---|
Chemspider ID | 110252 |
---|
KEGG Compound ID | Not Available |
---|
BioCyc ID | Not Available |
---|
BiGG ID | Not Available |
---|
Wikipedia Link | 3,5-Diiodothyronine |
---|
METLIN ID | 5564 |
---|
PubChem Compound | 123675 |
---|
PDB ID | Not Available |
---|
ChEBI ID | 350682 |
---|
Food Biomarker Ontology | Not Available |
---|
VMH ID | Not Available |
---|
MarkerDB ID | MDB00000193 |
---|
Good Scents ID | Not Available |
---|
References |
---|
Synthesis Reference | Valashek, I. E.; Kochergin, P. M.; Vinogradova, E. M.; Budanova, L. I. Synthesis of 3,5-diiodo-DL-thyronine. Khimiko-Farmatsevticheskii Zhurnal (1995), 29(6), 44. |
---|
Material Safety Data Sheet (MSDS) | Download (PDF) |
---|
General References | - Goglia F: Biological effects of 3,5-diiodothyronine (T(2)). Biochemistry (Mosc). 2005 Feb;70(2):164-72. [PubMed:15807655 ]
- Nishikawa M, Inada M, Naito K, Ishii H, Tanaka K, Mashio Y, Imura H: Serum concentrations of 3, 3'-diiodothyronine, 3', 5'-diiodothyronine, and 3, 5-diiodothyronine in altered thyroid states. Endocrinol Jpn. 1983 Apr;30(2):167-72. [PubMed:6641638 ]
- Takeshita A: [Monoiodothyronine and diiodothyronine]. Nihon Rinsho. 1999 Dec;57 Suppl:86-9. [PubMed:10778070 ]
- Pinna G, Meinhold H, Hiedra L, Thoma R, Hoell T, Graf KJ, Stoltenburg-Didinger G, Eravci M, Prengel H, Brodel O, Finke R, Baumgartner A: Elevated 3,5-diiodothyronine concentrations in the sera of patients with nonthyroidal illnesses and brain tumors. J Clin Endocrinol Metab. 1997 May;82(5):1535-42. [PubMed:9141546 ]
- Martinez MB, Ruan M, Fitzpatrick LA: Altered response to thyroid hormones by breast and ovarian cancer cells. Anticancer Res. 2000 Nov-Dec;20(6B):4141-6. [PubMed:11205239 ]
- Faber J, Heaf J, Kirkegaard C, Lumholtz IB, Siersbaek-Nielsen K, Kolendorf K, Friis T: Simultaneous turnover studies of thyroxine, 3,5,3' and 3,3',5'-triiodothyronine, 3,5-, 3,3'-, and 3',5'- diiodothyronine, and 3'-monoiodothyronine in chronic renal failure. J Clin Endocrinol Metab. 1983 Feb;56(2):211-7. [PubMed:6401746 ]
- Kirkegaard C, Faber J, Siersbaek-Nielsen K, Friis T: A radioimmunoassay of serum 3,5-diiodothyronine. Acta Endocrinol (Copenh). 1981 Jun;97(2):196-201. [PubMed:7234287 ]
- Jaedig S, Faber J: The effect of starvation and refeeding with oral versus intravenous glucose on serum 3,5-,3,3'-and 3'-5'-diiodothyronine and 3'-monoiodothyronine. Acta Endocrinol (Copenh). 1982 Jul;100(3):388-92. [PubMed:7113605 ]
- Engler D, Merkelbach U, Steiger G, Burger AG: The monodeiodination of triiodothyronine and reverse triiodothyronine in man: a quantitative evaluation of the pathway by the use of turnover rate techniques. J Clin Endocrinol Metab. 1984 Jan;58(1):49-61. [PubMed:6689682 ]
- Baur A, Bauer K, Jarry H, Kohrle J: 3,5-diiodo-L-thyronine stimulates type 1 5'deiodinase activity in rat anterior pituitaries in vivo and in reaggregate cultures and GH3 cells in vitro. Endocrinology. 1997 Aug;138(8):3242-8. [PubMed:9231774 ]
- Engler D, Burger AG: The deiodination of the iodothyronines and of their derivatives in man. Endocr Rev. 1984 Spring;5(2):151-84. [PubMed:6376077 ]
- Hommel E, Faber J, Kirkegaard C, Siersbaek-Nielsen K, Friis T: Urinary excretion of unconjugated and conjugated 3,5-diiodothyronine. Horm Metab Res. 1985 Feb;17(2):90-2. [PubMed:3988241 ]
- Senese R, de Lange P, Petito G, Moreno M, Goglia F, Lanni A: 3,5-Diiodothyronine: A Novel Thyroid Hormone Metabolite and Potent Modulator of Energy Metabolism. Front Endocrinol (Lausanne). 2018 Jul 25;9:427. doi: 10.3389/fendo.2018.00427. eCollection 2018. [PubMed:30090086 ]
- Antonelli A, Fallahi P, Ferrari SM, Di Domenicantonio A, Moreno M, Lanni A, Goglia F: 3,5-diiodo-L-thyronine increases resting metabolic rate and reduces body weight without undesirable side effects. J Biol Regul Homeost Agents. 2011 Oct-Dec;25(4):655-60. [PubMed:22217997 ]
|
---|